Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 (Q61969619)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2
clinical trial

    Statements

    short name
    TRAIN-2 (English)
    0 references
    title
    Optimizing Neoadjuvant Systemic Treatment for HER2 Positive Breast Cancer - the TRAIN-2 Study (English)
    0 references
    country
    Netherlands
    0 references
    start time
    December 2013
    0 references
    end time
    December 2018
    0 references
    number of participants
    437
    0 references
    research intervention
    paclitaxel
    0 references
    pertuzumab
    0 references
    (RS)-cyclophosphamide
    0 references
    carboplatin
    0 references
    trastuzumab
    0 references
    fluorouracil
    0 references
    epirubicin
    0 references
    minimum age
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q61969619&oldid=2101388185"